Back to Clinical Trials Overview

Your search for "Children's Health" returned 39 results:


Imaging Stimulant and Non-Stimulant Treatments for ADHD: A Network Based Approach
Principal Investigator(s): Jeffrey Newcorn

The Neuroimmunology of Anhedonia
Principal Investigator(s): Gabbay, Vilma

AMPLATZER Duct Occluder II in patients with a patent ductus arteriosus clinical study (ADO II Clinical Study)
Principal Investigator(s): Barry Love

Milk Oral Immunotherapy (OIT) plus Xolair® (anti-IgE) (ages 7-35 years)
Principal Investigator(s): Sampson, Hugh

A Pilot Study of SD-809 (deutetrabenazine) in Moderate to Severe Tourette Syndrome
Principal Investigator(s): Barbara Coffey

A Randomized, Double-Blind, 12-week, Parallel Group, Placebo-Controlled Study of the Efficacy and Safety of RO4917523 in Patients with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

Autistic endophenotypes and their associations to oxytocin and cholesterol
Principal Investigator(s): Silverman, Jeremy

Attention Deficit Hyperactivity Disorder Study
Principal Investigator(s): Jeffrey Newcorn

Neuroinflammation and Positive Valence System Deficits in Adolescents
Principal Investigator(s): Vilma Gabbay

Clinical Study of Chinese Herbal Medicine for Inflammatory Bowel Disease
Principal Investigator(s): Dunkin, David

A 6-Month, Multicenter, Randomized, Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy Study of AZD5213 in Adolescents with Tourette's Disorder (TD)
Principal Investigator(s): Barbara Coffey

Baked Milk Study (ages 4-10 years)
Principal Investigator(s): Sampson, Hugh

Evaluating Behavioral & Neural Effects of Social Skills Treatment for School-Age Children with Autism Spectrum Disorders
Principal Investigator(s): Wang, A. Ting & Soorya, Latha

Anaphylaxis Therapies (ages 0-17 years)
Principal Investigator(s): Nowak-Wegrzyn, Anna

Phelan-McDermid Syndrome: Insights into Synaptic Pathology and Novel Therapeutics in ASD
Principal Investigator(s): Alexander Kolevzon

Evidence-based Practices for Interventions to Improve the Health and Well-being of Children with Autism Spectrum Disorders
Principal Investigator(s): Alexander Kolevzon

Genetics & Neuroendocrinology of Short Stature
Principal Investigator(s): Rapaport, Robert

A multi-site, double-blind, placebo-controlled trial of memantine vs. placebo in children with autism targeting memory and motor planning
Principal Investigator(s): David Grodberg

Defining the optimal dose of caudal-Epidural Morphine in Pediatric Cardiac Surgery
Principal Investigator(s): Hollinger, Ingrid

Community Partnership to Prevent Urban HIV Risk
Principal Investigator(s): McKay, Mary M

Metabolic effects of antiretrovirals in exposed HIV seronegative children
Principal Investigator(s): Jao, Jennifer, MD

Piloting Treatment with Insulin-Like Growth Factor-1 (IGF-1) in Phelan McDermid Syndrome
Principal Investigator(s): Alexander Kolevzon

H80-MC-GWBQ Efficacy of Exenatide in Adolescent Patients with Type 2 Diabetes
Principal Investigator(s): Rapaport, Robert

A Multi-center, double-blind, randomized study evaluating de novo weekly and once every 2 week darbepoetin alfa dosing for the correction of anemia in pediatric subjects with chronic kidney disease recieving and not receiving dialysis
Principal Investigator(s): Benchimol, Corinne

Vincritine, Dactinomycin and Cyclophosphomaide for Rhabdomyosarcoma (Sarcoma)
Principal Investigator(s): Birte Wistinghausen

Attention Deficit Hyperactivity Disorder Study: Methylphenidate v. Atomoxetine
Principal Investigator(s): Jeffrey Newcorn

A Randomized, Double-blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Children with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

Bacterial Transmission In Utero and IBD Risk: The MECONIUM Study
Principal Investigator(s): Inga Peter

A randomized, parallel-group, double-blind, placebo-controlled, safety and exploratory efficacy and pharmacokinetic study of R04917523 in pediatric patients with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

Phase III Randomized Study of Chimeric Anti-GC2 in high risk neuroblastoma following myeloablative therapy and autologous stem cell rescue (Protocol - ANBL0032) (Brain)
Principal Investigator(s): Birte Wistinghausen

National Children's Study - Monroe County
Principal Investigator(s): Landrigan, Philip

Intensified Methotrexate,Nelarabine & Augmented BFM Ther (AALL0434)
Principal Investigator(s): Birte Wistinghausen

Food Protein-Induced Enterocolitis Syndrome - FPIES (ages 6 months-21 years)
Principal Investigator(s): Nowak-Wegrzyn, Anna

Immunological Response to Chinese Herbal Medicine on Food Allergy
Principal Investigator(s): Wang, Julie

Near Infrared Spectroscopy in Children Undergoing Congenital Heart Surgery
Principal Investigator(s): Mittnacht, Alexander

ARST0332: Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Principal Investigator(s): Birte Wistinghausen

A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism
Principal Investigator(s): Alexander Kolevzon

Chronic Kidney Disease in Children Study (C-Kid)
Principal Investigator(s): Saland, Jeffrey M

An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI®) in Pediatric Subjects under Two Years of Age with Urea Cycle Disorders (UCDs)
Principal Investigator(s): George Diaz